Literature DB >> 7653476

Methodology for evaluating the incidence of second primary cancers with application to smoking-related cancers from the Surveillance, Epidemiology, and End Results (SEER) program.

C B Begg1, Z F Zhang, M Sun, H W Herr, S P Schantz.   

Abstract

The Surveillance, Epidemiology, and End Results (SEER) database is used to estimate the standardized incidence ratios (SIRs) of second primaries for all pairs of smoking-related cancers and to interpret the results in the context of our knowledge of the known effects of smoking on the incidence of each of the individual cancers. In evaluating the simultaneous incidence of two cancers, one must recognize the inherent duality of the two relevant SIRs linking the two cancers (e.g., A and B), namely, the SIRs of A following B and B following A. Under fairly general assumptions, the two SIRs are seen to be equal, and departures from equality suggest changes in risk status or the introduction of new risk factors after the incidence of the first primary. Based on these observations, a methodological strategy is developed. The data reveal several clear patterns. First, short-term incidence is uniformly much greater than long-term incidence. Second, the SIRs are consistently much higher for women than for men, for every pair of cancers studied. Third, the magnitudes of the SIRs are generally high and often substantially higher than would be expected on the basis of the known risks of smoking. Exceptionally high SIRs are observed between kidney and bladder cancer and between head and neck and esophageal cancer. Various influences may affect these high observed SIRs, including artifactual influences such as diagnostic, surveillance, and misclassification biases, and the effect of different exposure prevalences on subsequent SIRs, which may to some extent explain the strong sex differences. However, these artifacts do not appear to explain the magnitude of the observed SIRs, especially the very strong associations between kidney and bladder cancer and between head and neck and esophageal cancer. It seems likely that other factors play a role, including, possibly, host susceptibility factors or additional common risk factors other than smoking. Although multiple primary cancers are rare, they represent an especially fruitful population for detailed epidemiologic study.

Entities:  

Mesh:

Year:  1995        PMID: 7653476     DOI: 10.1093/oxfordjournals.aje.a117689

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  15 in total

1.  Predictors of survival and recurrence after temporal bone resection for cancer.

Authors:  Luc G T Morris; Saral Mehra; Jatin P Shah; Mark H Bilsky; Samuel H Selesnick; Dennis H Kraus
Journal:  Head Neck       Date:  2011-09-23       Impact factor: 3.147

2.  Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer.

Authors:  Luc G T Morris; Andrew G Sikora; Snehal G Patel; Richard B Hayes; Ian Ganly
Journal:  J Clin Oncol       Date:  2010-12-28       Impact factor: 44.544

3.  The search for cancer risk factors: when can we stop looking?

Authors:  C B Begg
Journal:  Am J Public Health       Date:  2001-03       Impact factor: 9.308

4.  Second primary malignancies in renal cortical neoplasms: an updated evaluation from a single institution.

Authors:  Katie S Murray; Emily C Zabor; Massimiliano Spaliviero; Paul Russo; Wassim M Bazzi; John E Musser; A Ari Hakimi; Melanie L Bernstein; Guido Dalbagni; Jonathan A Coleman; Helena Furberg
Journal:  World J Urol       Date:  2016-04-22       Impact factor: 4.226

5.  Increased risk of second primary malignancy in pediatric and young adult patients treated with radioactive iodine for differentiated thyroid cancer.

Authors:  Jennifer L Marti; Kunal S Jain; Luc G T Morris
Journal:  Thyroid       Date:  2015-05-06       Impact factor: 6.568

6.  Incidence and Risk of Second Primary Malignant Neoplasm After a First Head and Neck Squamous Cell Carcinoma.

Authors:  Eric Adjei Boakye; Paula Buchanan; Leslie Hinyard; Nosayaba Osazuwa-Peters; Mario Schootman; Jay F Piccirillo
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-08-01       Impact factor: 6.223

7.  Anatomic sites at elevated risk of second primary cancer after an index head and neck cancer.

Authors:  Luc G T Morris; Andrew G Sikora; Richard B Hayes; Snehal G Patel; Ian Ganly
Journal:  Cancer Causes Control       Date:  2011-02-15       Impact factor: 2.506

Review 8.  Biological staging of head and neck cancer and its role in developing effective treatment strategies.

Authors:  W M Lydiatt; S P Schantz
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

9.  The risk for malignant primary adult-onset glioma in a large, multiethnic, managed-care cohort: cigarette smoking and other lifestyle behaviors.

Authors:  Jimmy T Efird; Gary D Friedman; Stephen Sidney; Arthur Klatsky; Laurel A Habel; Natalia V Udaltsova; Stephen Van den Eeden; Lorene M Nelson
Journal:  J Neurooncol       Date:  2004-05       Impact factor: 4.130

10.  Lymph node non-Hodgkin's lymphoma incidentally discovered during a nephrectomy for renal cell carcinoma.

Authors:  Sergio Fernandez-Pello; Luis Rodriguez Villamil; Ivan Gonzalez Rodriguez; Victoria Venta; Javier Cuervo; Carmen Luz Menéndez
Journal:  World J Clin Cases       Date:  2013-06-16       Impact factor: 1.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.